April 06, 2020
Generic versions of Metformin produced by Aurobindo Pharma and Heritage Pharmaceuticals were contaminated with a possible carcinogen, according to a proposed Florida class action seeking to recover $124 million that health insurers paid for the popular diabetes drug.